Women who have an early menopause are unlikely to have a long term increased risk of hip fractures associated with menopausal bone density weakening, according to a new study from The Australian National University.

Molecular dermatology research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC, pioneers of genetic tests for predicting the risk of male and female hair loss, today introduced The HairDX (RxR) Genetic Test for Finasteride – a breakthrough genetic test for predicting Finasteride response for the treatment of common hair loss (Androgenetic Alopecia).

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously shown to play a role in a person’s susceptibility to depression, activates a serotonin receptor in [...]

Industry-sponsored studies on influenza vaccines are published in journals with higher rankings (impact factors) and are cited more than studies with other sponsors, but this is not because they are bigger or better, finds a study published on http://www.bmj.com today.

The amount of proteins produced in cells-a fundamental determinant of biological outcomes collectively known as gene expression-varies in African American individuals depending on their proportion of African or European genetic ancestry. These findings, by researchers based in Boston, Philadelphia and Oxford, are published December 5 in the open-access journal PLoS Genetics.